The incidence and risk for suicidality and self-harm were low for individuals given glucagon-like peptide-1 receptor agonists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback